ClinicalTrials.gov
ClinicalTrials.gov Menu

Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00226954
Recruitment Status : Completed
First Posted : September 27, 2005
Last Update Posted : July 28, 2009
Sponsor:
Collaborator:
Novartis
Information provided by:
Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2007
  Actual Study Completion Date : February 2009